We investigated HIV-1 diversity by means of heteroduplex mobility assay (HMA) genotyping. We studied 199 samples from patients originating from 26 countries and living in France. The HMA successfully genotyped 182 (91%) of these samples, as follows: 77 (42%) subtype A, 57 (31%) subtype B, 5 (3%) subtype C, 5 (3%) subtype D, 8 (4%) subtype E, 22 (12%) subtype F, 5 (3%) subtype G, and 3 (2%) subtype H. We were not able to genotype 12 samples by means of the HMA. These latter strains were sequenced, and phylogenetic analyses revealed that they were highly divergent subtype A-, D-, or G-related strains. Eight (of 12) subtype D strains were indeterminate by HMA, owing to the broad intrasubtype diversity, suggesting that new reference subtype D plasmids are required, as previously proposed. Thirty-seven strains belonging to the different subtypes were sequenced, and the results showed perfect concordance with the HMA results. Interlaboratory quality controls confirmed the reliability of the HMA for HIV-1 subtyping, despite the extensive viral variability. However, plasmid selection must be continuously revised to cover viral diversification.
INTRODUCTION
T LEAST 10 HIV-1 group M subtypes (or clades) have so A far been defied on the basis of relations among e m gene sequences.'T2 The potential biological significance of these genetic clusters remains to be established. The study of HN-1 subtypes is a prerequisite for vaccine trials, in order to establish the most appropriate antigen formulation? Moreover, HIV antibody screening tests may lack sensitivity for HIV-1 group O samples: and in the early seroconversion phase in non-B subtype HIV-1 infection? The study of H[Tv-1 subtype distribution also allows worldwide viral spread to be monitored: subtype prevalence can vary significantly from country to country and within population groups, and can change with time. 6 Although sequencing remains the most informative method for determining the HW-1 subtype, it is costly and lengthy, and requires highly qualified personnel. Alternative, less sophisticated methods of differentiating HIV-1 subtypes include serotypinz methods?-* the probe hybridization assay? and the heteroduplex mobility assay (HMA).'O>" The latter is considered the most effective after sequencing, being highly specific, rapid, and standardizable. Several molecular epidemiology studies have been performed with this technique, and the results show that the HMA is a reliable method for the study of J3V diversity in different population^.'^'^ The French National Agency for AIDS Research (Agence Nationale de Recherches sur le SIDA, ANRS; Paris, France) has decided to sponsor a prospective study of HIV-1 diversity in France, based on HMA genotyping in different laboratories, followed by sequencing of distant isolates. To prepare for this study, we evaluated the performance of the HMA in clinical practice, by (1) 
MATERIALS AND METHODS

Samples
West Afiica (n = 57), Asia (n = 3), and the Caribbean (n = 7).
PBMC isolation and DNA extraction
Peripheral blood mononuclear cells (PBMCs) were separated on a Ficoll gradient. After two washes in phosphate-buffered s a l i e (PBS), cells were pelleted and stored at -80°C. DNA was extracted as previously reported.I6
Polymerase chain reaction and heteroduplex mobility assay One microgram of DNA was first subjected to polymerase chain reaction (PCR) amplification using the ED3/ED12 primer pair. When ED3/ED12 amplification failed we used the ED5/ED14 primer pair. 13 The second round of amplification was performed with 5 pl of the first-round product, using the ES7/ES8 primer pair described by Delwart et PCR products were purified (gel extraction kit; Qiagen, Chatsworth, CA) and used as a template for sequencing with primers ES7 and ES8 in the Prism Ready Reaction Amplitaq FS dye terminator kit (Perkin-Elmer) on an automated DNA sequencer (373A sequencer, Applied Biosystems Foster City, CA). Multiple alignments of DNA and protein sequences were done using the Clustal W with manual editing. The sequences were gapstripped and a pairwise matrix was generated with the DNADIST program (PHYLIP package, version 3.5c)Jo Tree topology was inferred by neighbor joining with the Kimura two-parameter distance matrix (PHYLIP) and a transition/transversion ratio of 2. Bootstrap analysis was performed with the SEQBOOT (100 resamplings), DNADIST, NEIGHBOR, and CONSENSE programs (PHYLE' package). Maximum likelihood trees were created using the PHYLE' DNAML 3.56 program with a tr~sition-to-transversion ratio of 2.
Recombination events were checked using the Recombinant Identification Program (RIP).21
Interlaboratory evaluation: HMA quality control. Two groups of samples formed the quality control panel: 12 HMAi n d e t e d a t e samples and 13 samples genotyped by HMA as subtypes A to H. This panel will be subjected to a national HMA quality control study. It was first tested in three laboratories to assess the reliability of the approach. The participants' first-round amplification strategy differed. In the Montpellier ORSTOM laboratory and the Pasteur Institute laboratory, the first amplification step was done using the primer pairs ED5/ED12 and ED3/ED14.I3 The corresponding proviral DNA of all these samples was sequenced in the V3-V5 region. A larger quality control study including all laboratories perfonning the HMA in France is in progress.
RESULTS
-
Heteroduplex mobility assay
Viral DNA Amplification. The genotyping strategy is presented in Fig. 1 . The PCR was perfomed using the ED3ED12 primer pair on all the available samples (n = 199) from patients originating from Africa, Asia, and the Caribbean, and on a subset of samples from European patients. In the 17 cases in which nested amplification with ES7/ES8 primers failed, ED5/ED14 primers were used for the fust PCR.'O Using both sets of primers we succeeded in amplifying the viral DNA in 190 of the 199 samples (96%). The remaining nine samples originated from Africans or from Caucasians sexually infected by African subjects. All nine PBMC samples were subjected to XL-PCR, which successfully amplified four of them; Nested PCR was then performed with inner primers ES7/ES8. All samples were positive for HLA-DQa amplification. This study included the samples that gave an indeterminate HMA result (n = 12), and 37 samples genotyped by HMA (8 A , 2 B , 2 C , l D , l E , l g F , 2 G , a n d 2 H ) . Phylogenetic analysis of HMA-indeterminate samples. Phylogenetic &es were constructed using the C2V3 env sequences of HMA-indeterminate viruses and a wide range of subtype A (Fig. 2a) , subtype D (Fig. 2b) , and subtype G (Fig. 2c) strains. Representative group M strains were also included in these trees, together with unclassified, highly divergent env sequences from the HIV database.l As shown in Fig. 2a , three HMA-indeterminate samples classified as subtype A outliers in the preliminary phylogenetic analysis were highly divergent strains were included in the tree construction. Sequences determined in this study are boxed. HMA-indetexminate samples are designated by asterisks (*). Tree topologies were inferred by neighbor joining with the Kimura two-parameter distance matrix (PHYLIP).
HMA genotyping results.
The numbers at nodes indicate the frequency with which each node occurred in 100 bootstrap replicates, and are restricted to values greater than 50%. Brackets and letters on the right indicate the subtype classification. GenBank accession numbers for the newly reported sequences are 295438-295473.
and clustered with unclassified sequences originating from recombinant strains.' The first strain (BCB72) was isolated from a patient from the Ivory Coast and 'clustered with strain CAR4081 (Fig. Za) , with a high bootstrap value (loo%), The genetic distance between BCB72 and subtype A ranged from 14.4 to 28.0%, whereas the distance between BCB72 and CAR4081 was 9.3%. The latter was considered as U (uncertain) before being shown to be an A/G recombinant strain,' but it was classified as subtype A on the basis of the envelope region used to construct our tree. The clustering of BCB72 and CAR4081 as subtype A outliers in our preliminary analysis, together with the indeterminate HMA pattem of BCB72, raised the question of whether BCB72 was a recombinant virus. The second strain (BCB69) originated from a Malian patient. The genetic distance between this strain and subtype A ranged from 18.7 to 24.5%. The shortest distance was found with recombina$ strain ZAM184 (12.1%), with which it clustered with a high bootstrap value (100%). ZAM184 is an A/C recombinant strain.' The env sequence of strain M l 8 4 used in this analysis had a recombinant structure corresponding to subtypes A (239 bp) and C (246 bp). The third strain (BCBM), which was also isolated from a patient from the Ivory Coast, gave an uncertain classification result. The phylogenetic analysis revealed that this strain did not cluster with any of the subtype A strains from the HIV databases. Similar results were obtained for these three strains by using maximum likelihood analysis (data not shown). By sequencing we identified 13 subtype D samples in our study group, only 5 of which were correctly genotyped by HMA ( Table 1 ). The status of subtype D reference plasmids (DI, D2, and D3) used in our study was confiied by sequencing.
Two HMA-indeteminate, highly divergent subtype D strains were isolated from patients originating from Cameroon (BCB88) and Cape Verde (BCB93). Interestingly, the phylogenetic analysis revealed that one of these HMA-indeterminate subtype D strains (BCB88) and an HMA-genotyped isolate 
FIG. 2. (continued)
(BCB90) were highly related (bootstrap value of 75). Although the reasons for this segregation of HMA results are not clear, the discrepancy observed between HMA and the phylogenetic analysis for patient BCB88 could be explained by the presence of insertions in the ES7/ES8 regions of this isolate relative to the reference sequences. Figure 3 depicts the amino acid alignments for these three subtype D strains and the D1, D2, and D3
plasmids. As can be observed, HMA-indeterminate strain amino acid sequences are longer than subtype D plasmid sequences and the BCB90 sequence, the insertions in the nucleotide sequences forming gaps and thus generating indeterminate patterns.
The presence in our study group of six new indeterminate subtype D strains (BCB74, BCB86, BCB87, BCB89, BCB91, and BCB92) drastically influenced the efficiency of subtype D genotyping by means of the HMA. A possible explanation for the failure to genotype the subtype D strains is the heterogeneity of our study group. The neighbor-joining tree (Fig. 2b) (Fig. 2b) . Although this phylogenetic group was not defined by high bootstrap values, it was also found by using the maximum likelihood method (data not shown). The failure of HMA genotyping in these cases might thus be explained'by sequence data. The mean genetic distance was 27% (range, 15-37%) within the divergent D group, 29.5% (range, 20-38%) between this group and the three subtype D reference plasmids, and 20% (range, 17-25%) between the three reference plasmids and other subtype D strains. HMA-indeterminate samples originated from patients from West and Central Africa, whereas the three subtype D reference plasmids are from Uganda and so do not cover all subtype D diversity.
Sequence analysis of the latest HMA-nontypable strain (BCB73) classified this strain as a distant subtype G (Fig. 2c) . The genetic distance between BCB73 and subtype G was 28% (range, 21-34%), whereas it was 20% within subtype G (range, 6-25%).
The analysis by RIP of the breaking points in the HMA-indeterminate sequences revealed continuous structures for all but one sequence (BCB69). This later sequence presented a configuration close to that of ZAMl84, an A/C recombinant strain, the same recombination junction being shared by the two sequences. Sequencing of the complete genome of distant strains (BCB69, BCB72, BCB64, and BCB73) is underway to determine if they correspond to new subtypes or intrasubtype recombinants.
HMA quality control study
All HMA-indeterminate samples and a panel of HIV-1 isolates belonging to subtypes A to H were subjected to blind HMA testing in three separate laboratories. In the frst amplification step the primers used by the virology laboratory of BichatClaude Bemard Hospital (ED3/ED12 or ED5/ED14) differed from those used by the other participants, i.e., ED5/ED12 or ED3BD14, as recommended by Delwart et al." However, the
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DISCUSSION
This study confirms that HMA is an effective HJY-1 subtyping method, classifying 91% of 199 clinical HN-1 isolated.
The strategy we used ( Fig. 1) positively amplified all but'five samples originating from African patients. In these five cases the failure of XL-PCR amplification could have been due to a low viral load, or to the existence of highly divergent HIV-1 strains in our s&dy group.
In 12 cases the HMA failed to establish the HIV-1 genotype despite positive PCR amplification. The samples that gave indeterminate HMA results were either from African patients or from Caucasians sexually infected by African partners. They mainly corresponded to subtype D or to highly divergent strains with an uncertain classification, as demonstrated by sequence analysis. These data are in agreement with a report on HMAnontypable samples from patients infected by divergent subtype A and D viruses.23 Our phylogenetic analysis indicated that these viruses were highly divergent strains; this was the case of the three HMA-nontypable subtype A samples tested. The detection of highly divergent subtype A-related viruses in our study group might be explained by the large number of samples from patients originating from Africa, where subtype A prevails. Despite the wide intrasubtype A variability, HMA remained a reliable subtyping approach, as it succeeded in genotyping 77 subtype A viruses in our study group. Also, despite the puzzling structure of recombinant strains, the HMA oriented our subsequent investigations of three very divergent strains, two of which were related to recombinant strains.
As regards subtype D viruses, the high proportion of HMAindeterminate results was related to problems with the reference plasmids, which were constructed with env sequences of viruses from Uganda, a site selected by the World Health Or- The last HMA-indeterminate sample also diverged from other previously reported subtype G strains, which may explain its no identification by HMA (Fig. 2c) . Subtype G reference plasmids were selected when a limited number of subtype G sequences were available?1 HMA subtype G detection might thus be improved by the use of new reference plasmids.
Intralaboratory HMA quality control showed no discrepancy between the HMA and sequencing results. Interlaboratory analysis proved to be useful for the assessment of HMA reliability in a national survey. The three participants h the interlaboratory quality control correctly genotyped HIV-1 strains belonging to different subtypes. None of the participants was able to identify the highly divergent subtype A strains or the very divergent subtype D strains that formed a separate group within the subtype D cluster. However, different results were observed for two subtype D samples.
Previous reports have suggested that the HMA is an effective method for evaluating the genetic diversity of HIV-1 in different geographic regions.
However Our study showed that as HN-1 diversification appeais to be a continuous and dynamic phenomenon, the HMA should be adapted periodically by renewing the plasmids, as proposed by Delwart et aZ.IO
